Cellular signalling pathways and pathophysiology of pulmonary arterial hypertension;Signalisation cellulaire et physiopathologie de l'hypertension artérielle pulmonaire

Revue des Maladies Respiratoires

Volumn 23, Issue 1, 2006, Pages

  Dao, P ^a   Montani, D ^b   Duong Quy, S ^a   Dinh Xuan, A T ^a  

^a Institut Cochin   (France)

^b UPRES EA2705   (France)

Author keywords

Biology; cGMP; Endothelin receptors ET A and ET B; Endothelin 1; Nitric oxide; NO synthase; Phosphodiesterase 5; Pulmonary arterial hypertension; Soluble guanyl cyclase

Indexed keywords

CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; GUANYLATE CYCLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PHOSPHODIESTERASE V;

ARTICLE; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CHROMOSOME 1; CHROMOSOME 20; CHROMOSOME 6; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; LUNG CIRCULATION; LUNG VASCULAR RESISTANCE; PATHOPHYSIOLOGY; PULMONARY HYPERTENSION; RESPIRATORY SYSTEM; SMOOTH MUSCLE TONE; VASCULAR SMOOTH MUSCLE; AMINO TERMINAL SEQUENCE; BIOSYNTHESIS; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CELL DIFFERENTIATION; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME SYNTHESIS; HEART INDEX; HEART MUSCLE CELL; LUNG BLOOD VESSEL; LUNG VASOCONSTRICTION; MOLECULAR BIOLOGY; MUSCLE RELAXATION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASODILATATION; VEIN DILATATION;

EID: 33645720494     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0761-8425(06)73418-0     Document Type: Short Survey

References (58)

1. Dinh-Xuan AT : Endothelial modulation of pulmonary vascular tone. Eur Respir J 1992 ; 5 : 757-62.
2. Montani D, Jaïs X, Sitbon O, Capron F, Simonneau G, Humbert M : Hypertension artérielle pulmonaire. Rev Mal Respir 2005 ; 22 : 651-66.
3. Weitzenblum E : Actualité sur l'hypertension artérielle pulmonaire « idiopathique ». Rev Mal Respir 2004 ; 21 : 7S82-5.
4. Moncada S, Higgs EA : The L-arginine-nitric oxide pathway. N Engl J Med 1993 ; 329 : 2002-12.
5. Barnes PJ, Karin M : Nuclear factor-κB - a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-71.
6. Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G : Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004 ; 84 : 731-65.
7. Friebe A, Koesling D : Regulation of nitric oxide-sensitive guanylyl cyclase. Circ Res 2003 ; 93 : 96-105.
8. Lucas KA, Pitari GM, Kazerounian S, Ruiz Stervart I, Park J, Schulz S, Chepenik KP, Waldam SA : Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 2000 ; 52 : 375-414.
9. Martin E, LeeYC, Murad F : YC-1 activation of human sGC has both heme dependent and heme independent components. Proc Natl Acad Sc USA 2001 ; 98 : 12938-42.
10. Behrends S, Kempfert J, Mietens A, Kaglin M, Scholz H, Middendorff R : Developmental changes of nitric oxide sensitive sGC expression in pulmonary arteries. Biochem Biophys Res Commun 2001 ; 283 : 883-7.
11. Schmidt K, Schrammel A, Koesling D, Mayer B : Molecular mechanisms involved in the synergistic activation of soluble guanylyl cyclase by YC-1 and NO in endothelial cells. Mol Pharmacol 2001 ; 59 : 220-4.
12. Stash JP, Becker EV, Schram M : NO independent regulatory site on soluble guanylate cyclase. Nature 2001 ; 410 : 212-5.
13. Friebe A, Koesling D : Mechanism of YC-1 induced activation of soluble guanylyl cyclase. Mol Pharmacol 1998 ; 53 : 123-7.
14. Rothermund L, Friebe A, Paul M, Koesling D, Kreutz R : Acute blood pressure effects of YC-1 induced activation of sGC in normotensive rats. Br J Pharmacol 2000 ; 130 : 205-8.
15. Brunner F, Schmidt K, Nielsen EB, Mayer B : Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery. J Pharmacol Exp Ther 1996 ; 277 : 48-53.
16. Münzel T, Feil R, Mulsch A, Lohmann SM, Hofmann F, Walter U : Physiology and pathophysiology of vascular signaling controlled by guanosine 3′,5′-cyclic monophosphate-dependent protein kinase. Circulation 2003 ; 108 : 2172-83.
17. Takeda K, Klepper M : Voltage-dependent and agonist activated ionic currents in vascular endothelial cells: a review. Blood Vessels 1990 ; 27 : 169-83.
18. 2+ entry by YC-1, an activator of soluble guanylyl cyclase, through a cyclic GMP-independent pathway in rat neutrophils. Biochem Pharmacol 2001 ; 62 : 679-84.
19. Rybalkin SD, Yan C, Bornfeldt KE, Beavo JA : Cyclic GMP phosphodiesterases and regulation of smooth muscle function. Circ Res 2003 ; 93 : 280-91.
20. Matsumoto T, Kobayashi T, Kamata K : Phosphodiesterases in the vascular system. J Smooth Muscle Res 2003 ; 39 : 67-86.
21. Galle J, Zabel U, Hubner U, Schmidt H : Effects of the soluble guanylyl cyclase activator, YC-1 on vascular tone, cyclic GMP levels and phosphodiesterase activity. Br J pharmacol 1999 ; 127 : 195-203.
22. Dinh-Xuan AT : Disorders of endothelium-dependent relaxation in pulmonary disease. Circulation 1993 ; 87 (Suppl V) : V81-7.
23. Dinh-Xuan AT, Higenbottam TW, Clelland CA, Pepke-Zaba J, Wells FC, Wallwork J : Acetylcholine and adenosine diphosphate cause endothelium-dependent relaxation of isolated human pulmonary arteries. Eur Respir J 1990 ; 3 : 633-8.
24. + channel blockade inhibits shear stress-induced pulmonary vasodilatation in the ovine fetuses. Am J Physiol Lung Cell Mol Physiol 1999 ; 276 : L220-8.
25. Adnot S, Raffestin B, Eddahibi S, Braquet P, Chabrier P-E : Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest 1991 ; 87 : 155-62.
26. Dinh-Xuan AT, Higenbottam TW, Clelland CA, Pepke-Zaba J, Cremona G, Butt AY, Large SR, Wells FC, Wallwork J : Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med 1991 ; 324 : 1539-47.
27. Dinh-Xuan AT, Higenbottam TW, Pepke-Zaba J, Clelland CA, Wallwork J : Reduced endothelium-dependent relaxation of cystic fibrosis pulmonary arteries. Eur J Pharmacol 1989 ; 163 : 401-3.
28. Dinh-Xuan AT, Higenbottam TW, Wallwork J : Relationship between chronic hypoxia and in vitro pulmonary relaxation mediated by endothelium-derived relaxing factors in human chronic obstructive lung disease. Angiology 1992 ; 43 : 350-6.
29. Dinh-Xuan AT, Pepke-Zaba J, Butt AY, Cremona G, Higenbottam TW. Impairment of pulmonary-artery endothelium-dependent relaxation in chronic obstructive lung disease is not due to dysfunction of endothelial cell membrane receptors nor to L-arginine deficiency. Br J Pharmacol 1993 ; 109 : 587-91.
30. Dinh-Xuan AT, Higenbottam TW, Clelland CA, Pepke-Zaba J, Cremona G, Wallwork J : Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome. Br J Pharmacol 1990 ; 99 : 9-10.
31. Dinh-Xuan AT, Cremona G, Higenbottam TW : Endothelial dysfunction and remodelling of the pulmonary circulation in chronic hypoxic pulmonary hypertension. Appl Cardiopulmon Pathophysiol 1994 ; 5 : 93-9.
32. Hassoun PM : Deciphering the 'matrix' in pulmonary vascular remodelling. Eur Respir J 2005 ; 25 : 778-9.
33. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T : A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988 ; 332 : 411-5.
34. Eguchi S, Hirata Y, Imai T, Marumo F : Endothelin-1 as an autocrine growth factor for endothelial cells. J Cardiovasc Pharmacol 1995 ; 26 (Suppl 3) : S279-83.
35. Lüscher TF, Barton M : Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation 2000 ; 102 : 2434-40.
36. Kishi F, Minami K, Okishima N, Murakami M, Mori S, Yano M, Niwa Y, Nakaya Y, Kido H. Novel 31-amino-acid-length endothelins cause constriction of vascular smooth muscle. Biochem Biophys Res Commun 1998 ; 248 : 387-90.
37. Davenport AP : International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol Rev 2002 ; 54 : 219-26.
38. Masaki T, Miwa S, Sawamura T, Ninomiya H, Okamoto Y : Subcellular mechanisms of endothelin action in vascular system. Eur J Pharmacol 1999 ; 375 : 133-8.
39. B receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med 2002 ; 165 : 398-405.
40. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994 ; 89 : 1203-8.
41. Bonvallet ST, Oka M, Yano M, Zamora MR, McMurtry IF, Stelzner TJ : BQ123, an ETA receptor antagonist, attenuates endothelin-1-induced vasoconstriction in rat pulmonary circulation. J Cardiovasc Pharmacol 1993 ; 22 : 39-43.
42. Haynes WG, Strachan FE, Webb DJ : Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation 1995 ; 92 : 357-63.
43. Strachan FE, Crockett TR, Mills NL, Gray GA, Webb DJ : Constriction to ETB receptor agonists, BQ-3020 and sarafotoxin s6c, in human resistance and capacitance vessels in vivo. Br J Clin Pharmacol 2000 ; 50 : 27-30.
44. Hirata Y, Emori T, Eguchi S, Kanno K, Imai T, Ohta K, Marumo F : Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 1993 ; 91 : 1367-73.
45. Shichiri M, Kato H, Marumo F, Hirata Y : Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells. Hypertension 1997 ; 30 : 1198-203.
46. Dupuis J, Goresky CA, Fournier A : Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors. J Appl Physiol 1996 ; 81 : 1510-5.
47. Haynes WG, Ferro CJ, O'Kane KP, Somerville D, Lomax CC, Webb DJ : Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans. Circulation 1996 ; 93 : 1860-70.
48. Jozsef L, Khreiss T, Fournier A, Chan JS, Filep JG : Extracellular signal-regulated kinase plays an essential role in endothelin-1-induced homotypic adhesion of human neutrophil granulocytes. Br J Pharmacol 2002 ; 135 : 1167-74.
49. Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T : Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria. Am J Physiol Heart Circ Physiol 1988 ; 255 : H970-3.
50. Giaid A, Michel RP, Stewart DJ, Sheppard M, Corrin B, Hamid Q : Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis. Lancet 1993 ; 341 : 1550-4.
51. Dupuis J, Stewart DJ, Cernacek P, Gosselin G : Human pulmonary circulation is an important site for both clearance and production of endothelin-1. Circulation 1996 ; 94 : 1578-84.
52. Eddahibi S, Springall D, Mannan M, Carville C, Chabrier PE, Levame M, Raffestin B, Polak J, Adnot S : Dilator effect of endothelins in pulmonary circulation: changes associated with chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 1993 ; 265 : L571-80.
53. Bressollette E, Dupuis J, Bonan R, Doucet S, Cernacek P, Tardif JC : Intravascular ultrasound assessment of pulmonary vascular disease in patients with pulmonary hypertension. Chest 2001 ; 120 : 809-15.
54. Stewart DJ, Levy RD, Cernacek P, Langleben D : Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med 1991 ; 114 : 464-9.
55. Miyauchi T, Yorikane R, Sakai S, Sakurai T, Okada M, Nishikibe M, Yano M, Yamaguchi I, Sugishita Y, Goto K : Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline- induced pulmonary hypertension. Circ Res 1993 ; 73 : 887-97.
56. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid W, Stewart DJ : Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993 ; 238 : 1732-9.
57. Yamamoto K, Ikeda U, Mito H, Fujikawa H, Sekiguchi H, Shimada K : Endothelin production in pulmonary circulation of patients with mitral stenosis. Circulation 1994 ; 89 : 2093-8.
58. Rubens C, Ewert R, Halank M, Wensel R, Orzechowski HD, Schultheiss HP, Hoeffken G : Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest 2001 ; 120 : 1562-9.